
Bioorganic and medicinal chemistry (2020)
Update date:2022-08-05
Topics:
Aicher, Thomas D.
Baer, Brian R.
Boyd, Steven A.
Chicarelli, Mark D.
Condroski, Kevin R.
DeWolf, Walter E.
Fischer, John
Frank, Michele
Hingorani, Gary P.
Hinklin, Ronald J.
Lee, Patrice A.
Neitzel, Nickolas A.
Pratt, Scott A.
Singh, Ajay
Sullivan, Francis X.
Turner, Timothy
Voegtli, Walter C.
Wallace, Eli M.
Williams, Lance
Glucose flux through glucokinase (GK) controls insulin release from the pancreas in response to high levels of glucose. Flux through GK is also responsible for reducing hepatic glucose output. Since many individuals with type 2 diabetes appear to have an inadequacy or defect in one or both of these processes, identifying compounds that can activate GK could provide a therapeutic benefit. Herein we report the further structure activity studies of a novel series of glucokinase activators (GKA). These studies led to the identification of pyridine 72 as a potent GKA that lowered post-prandial glucose in normal C57BL/6J mice, and after 14d dosing in ob/ob mice.
View MoreContact:13736652831
Address:NO.273 SHANGHAI SOUTH STREET,LUQIAO DISTRICT,ZHEJIANG PROVINCE,CHINA.
Lyrin Industrial Corporation Limited
Contact:86-731-82571800
Address:Rm 2408,Asia Economy International Building,Shaoshan Road South,Yuhua District,Changsha,Hunan,China
Jiangsu Zenji Pharmaceuticals LTD
Contact:+86-025-83172562; +1-224-888-1133(USA)
Address:No.5 Xinmofan Road
Contact:+852 83038667
Address:Room 1502, 15th Floor, SPA Centre,53-55 Lockhart Road, Wanchai, Hong Kong
Contact:86 311 85902108 / 85902109
Address:room 1001-1005 ,huanghe Road ,shijiazhuang ,China
Doi:10.1002/jps.2600520919
(1963)Doi:10.1002/ejoc.201600267
(2016)Doi:10.1021/jo00267a005
(1989)Doi:10.1021/jo9017588
(2009)Doi:10.1246/bcsj.20110078
(2011)Doi:10.1002/mrc.4259
(2016)